Reasons of contra-indications, absolute or relative, of multifocals an progressive glasses may be objective and/or subjective. This work considers some principal of them. Their knowledge and the comprehension of their mechanisms must help the ophthalmologist to understand the reasons of some defeats and to avoid some others.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Evaluating the role of quantitative computed tomography perfusion parameters in differentiating hepatocellular carcinoma from other hepatic neoplasms.
Abdom Radiol (NY)
November 2024
All India Institute of Medical Sciences Bhubaneswar, Bhubaneswar, India.
Article Synopsis
- Differentiating liver tumors is crucial for appropriate treatment and prognosis, but non-invasive methods often struggle due to overlapping features in imaging.
- This study evaluated CT perfusion parameters in 48 patients to help distinguish hepatocellular carcinoma (HCC) from other liver tumors, using statistical analysis to identify significant perfusion metrics.
- Results indicated that blood volume (BV) was particularly effective in differentiating HCC from other tumors, achieving a sensitivity of 96.6% and specificity of 80% at a threshold of 8.3 ml/100 ml/min, alongside several other significant perfusion parameters.
Premium intraocular lens adoption: Insights from a national health insurance analysis.
J Formos Med Assoc
August 2024
Department of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan. Electronic address:
Background: This study explores the utilization patterns of premium and nonpremium intraocular lenses (IOLs) under Taiwan's National Health Insurance, given the potential out-of-pocket expenses incurred by cataract surgery patients.
Methods: A cross-sectional, population-based analysis was performed on patients who underwent IOL implantation between 2016 and 2020. IOLs were categorized into nonpremium and premium, with the latter further divided based on function.
Ocrelizumab-induced organizing pneumonia in multiple sclerosis: case report and literature review.
Arch Clin Cases
July 2024
Division of Intensive Care Medicine and Pulmonary Medicine, Northwell Health, Port Jefferson, NY, USA.
Patients with relapsing-remitting multiple sclerosis should be offered disease-modifying therapies as part of their management. Recommended options include integrin antagonist therapy including natalizumab as well as anti-CD20 monoclonal antibodies like, ocrelizumab, rituximab, ofatumumab, and ublituximab. These therapies reduce relapse rates and slow brain lesion accumulation.
View Article and Find Full Text PDFPathways to epilepsy surgery in children with tuberous sclerosis complex-associated epilepsy.
Rev Neurol (Paris)
October 2024
Assistance publique-Hôpitaux de Marseille, Reference Centre for Rare Epilepsies (member of the ERN network EPICARE), Marseille, France; Assistance publique-Hôpitaux de Marseille, Pediatric Neurology Department, Marseille, France.
Background: Previous studies showed the efficacy of epilepsy surgery in carefully selected children with epilepsy associated with tuberous sclerosis complex. However, how this selection is conducted, and the characteristics of the patients brought to surgery are still poorly described. By conducting a multicentric retrospective cohort study covering the practice of the last twenty years, we describe the paths leading to epilepsy surgery in children with epilepsy associated with tuberous sclerosis complex.
View Article and Find Full Text PDFA critical appraisal of the current landscape of resectable BRAF mutated colorectal liver metastases: a systematic review.
Chin Clin Oncol
August 2024
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Background: Patients with surgically resectable BRAF-mutated colorectal liver metastases (CRLM) or limited extrahepatic disease constitute a highly selective subgroup among BRAF-mutated patients, characterized by a more indolent disease biology. This is evident in their suitability for surgical resection. However, initial studies from a decade ago presented a discouraging outlook for these patients, citing early, frequent, multifocal recurrences and a very limited median overall survival (OS) of less than two years.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!